Tci Wealth Advisors, Inc. Gemini Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	BUY	$1.29 - $3.08 $258 - $616	200 New	200 $0
Q4 2021 Jan 24, 2022	SELL	$2.39 - $4.0 $1,195 - $2,000	-500 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$3.3 - $6.32 $330 - $632	100 Added 25.0%	500 $2,000
Q2 2021 Aug 02, 2021	BUY	$6.32 - $14.02 $1,264 - $2,804	200 Added 100.0%	400 $3,000
Q1 2021 Apr 29, 2021	BUY	$11.32 - $18.0 $2,264 - $3,600	200 New	200 $3,000

2.44M

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.